+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparable effects of oral diltiazem and verapamil in the treatment of hypertrophic cardiomyopathy. Double-blind crossover study



Comparable effects of oral diltiazem and verapamil in the treatment of hypertrophic cardiomyopathy. Double-blind crossover study



Japanese Heart Journal 27(5): 701-715



The effects of oral diltiazem, 180 mg/day, were compared with those of oral verapamil, 240 mg/day, in 32 patients with hypertrophic cardiomyopathy (HCM), using a double-blind crossover study design. In the first treatment period, diltiazem and verapamil improved subjective complaints in 83% and 71% of those who were symptomatic in the baseline period. Maximal oxygen consumption on exercise stress test increased with verapamil by 2.9 +/- 4.2 ml/Kg/min (p less than 0.05), and tended to increase with diltiazem. Verapamil also reduced the amplitude of negative T wave. In the statistical analysis based on the crossover design, diltiazem and verapamil did not differ in global improvement, overall safety and global utility ratings. In addition, both drugs showed comparable effects on electrocardiographic and echocardiographic variables and exercise tolerance except for minor differences in diastolic blood pressure, T wave amplitude and peak exercise heart rate. On the other hand, verapamil tended to induce more serious side effects, forcing the discontinuation of medication in 3 patients. Therefore, the present study indicates that diltiazem is essentially equally as effective as verapamil and is preferable in the treatment of patients with HCM since it may exhibit fewer serious side effects.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 039614290

Download citation: RISBibTeXText

PMID: 3546779

DOI: 10.1536/ihj.27.701


Related references

A double-blind, placebo-controlled crossover trial of nadolol and verapamil in mild and moderately symptomatic hypertrophic cardiomyopathy. Journal Of The American College Of Cardiology. 21(7): 1672-1679, 1993

A double-blind, randomized, crossover comparison of equivalent (by weight) oral doses of verapamil and diltiazem in patients with mild to moderate hypertension. Journal of Cardiovascular Pharmacology 13(Suppl. 4): S68-S70, 1989

Comparison of the efficacy of verapamil and diltiazem in stable exercise angina. A double-blind and crossover study. Archives des Maladies du Coeur et des Vaisseaux 83(3): 393-398, 1990

Medical treatment of esophageal achalasia. Double-blind crossover study with oral nifedipine, verapamil, and placebo. Digestive Diseases and Sciences 36(3): 260-267, 1991

Assessment of dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy A randomized, double-blind, crossover study. Circulation 98(17 Suppl. ): I506, 1998

Comparative effects of oral verapamil and propranolol on platelet activation in angina pectoris a placebo controlled double blind crossover study. American Heart Association Monograph (91): II-323, 1982

Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). Circulation 99(22): 2927-2933, 1999

Clinical and hemodynamic evaluation of propranolol in combination with verapamil nifedipine and diltiazem in exertional angina pectoris a placebo controlled double blind randomized crossover study. American Journal of Cardiology 55(6): 680-687, 1985

Effects of captopril and diltiazem on proteinuria A crossover double-blind study. Journal of the American Society of Nephrology 7(9): 1322, 1996

Effectiveness of diltiazem in treatment of effort angina a double blind crossover study. European Review for Medical & Pharmacological Sciences 6(3): 555-566, 1984

Dual-chamber pacing for hypertrophic cardiomyopathy: A randomized, double-blind, crossover trial. Journal of the American College of Cardiology 29(2): 435-441, 1997

Evaluation of the calcium channel-blocking agents diltiazem and verapamil for treatment of feline hypertrophic cardiomyopathy. Journal of Veterinary Internal Medicine 5(5): 272-282, 1991

Treatment of stable angina of effort with verapamil: a double-blind, placebo-controlled randomized crossover study. Circulation 66(3): 569-574, 1982

Evaluation of the effects of verapamil, flunarizine, diltiazem, nimodipine and placebo in the prevention of hemicrania. A double-blind randomized cross-over study. La Clinica Terapeutica 134(2): 119-125, 1990

Evaluation of the effects of verapamil flunarizine diltiazem nimopidine and placebo for migraine prophylaxis a double blind randomized cross over study. Clinica Terapeutica 134(2): 119-125, 1990